Skip to main content
Caplight Logo









Ceruvia Lifesciences

Ceruvia Lifesciences

Private
Greenwich, ConnecticutHealthcare & Life Scienceshttps://ceruvialifesciences.com

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ceruvia Lifesciences operates in Healthcare & Life Sciences and is based in Greenwich, Connecticut. It was founded in 2017.

Ceruvia Lifesciences is a clinical-stage biopharmaceutical company that researches, develops, and commercializes neurotransformational medicines to treat psychiatric and neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Mental Health

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Ceruvia Lifesciences Comparables

Compare Ceruvia Lifesciences with similar companies based on industry and business-model similarity.

Ceruvia Lifesciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
B. More Inc.
88%
Lophora
86%
Delix Therapeutics
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Ceruvia Lifesciences Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Ceruvia Lifesciences. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Paul E. Bezodis

Fractional COO

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 301% MoM.

  • Jun 18, 2026

    Monthly visitors grew 102% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • receives_financingOct 28, 2026

    In Aug '26, Ceruvia Life Sciences receives an $8M investment that fully funds its planned integrated Phase 1/2 clinical program for BOL-148.

Book a demo to see all news

For institutional investors. Book with your work email.

Ceruvia Lifesciences Filings

Explore SEC and related filing metadata, where available.

Ceruvia Lifesciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Ceruvia Lifesciences's valuation, stock price, and market status.

Is Ceruvia Lifesciences a public or private company?

Ceruvia Lifesciences is a private company.

What is the current stock price of Ceruvia Lifesciences?

Ceruvia Lifesciences is a private company, so its shares have no public market price. Caplight tracks Ceruvia Lifesciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ceruvia Lifesciences worth (valuation)?

Valuation information for Ceruvia Lifesciences is not publicly available.

Can I buy Ceruvia Lifesciences stock?

Ceruvia Lifesciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ceruvia Lifesciences's last funding round?

Funding round information for Ceruvia Lifesciences is not publicly available.

Who are the main investors in Ceruvia Lifesciences?

Investor information for Ceruvia Lifesciences is not publicly disclosed.

Will Ceruvia Lifesciences IPO soon?

No public IPO plans have been announced for Ceruvia Lifesciences.

How can I track Ceruvia Lifesciences secondary market activity?

Caplight tracks bids, offers, and trades in Ceruvia Lifesciences's shares on secondary markets.

Firmographic Details

HeadquartersGreenwich, Connecticut
Employee Range3
Year Founded2017
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?